Mission Wealth Management LP lifted its holdings in Relx PLC (NYSE:RELX) by 4.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,700 shares of the technology company’s stock after purchasing an additional 501 shares during the period. Mission Wealth Management LP’s holdings in Relx were worth $262,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also made changes to their positions in the company. Private Advisor Group LLC purchased a new position in shares of Relx in the 2nd quarter valued at about $33,000. FNY Investment Advisers LLC purchased a new position in shares of Relx in the 3rd quarter valued at about $36,000. RMR Wealth Builders purchased a new position in shares of Relx in the 2nd quarter valued at about $42,000. Ellevest Inc. increased its stake in shares of Relx by 44.0% in the 2nd quarter. Ellevest Inc. now owns 2,800 shares of the technology company’s stock valued at $66,000 after purchasing an additional 856 shares in the last quarter. Finally, Parallel Advisors LLC increased its stake in shares of Relx by 149.1% in the 2nd quarter. Parallel Advisors LLC now owns 2,972 shares of the technology company’s stock valued at $70,000 after purchasing an additional 1,779 shares in the last quarter. Hedge funds and other institutional investors own 3.58% of the company’s stock.
Several research firms recently issued reports on RELX. UBS Group reiterated a “neutral” rating on shares of Relx in a report on Wednesday, July 15th. Berenberg Bank reiterated a “hold” rating on shares of Relx in a report on Thursday, July 30th. ABN Amro cut Relx from a “buy” rating to a “hold” rating in a report on Wednesday, June 24th. Barclays reiterated an “overweight” rating on shares of Relx in a report on Tuesday, July 7th. Finally, Zacks Investment Research upgraded Relx from a “sell” rating to a “hold” rating in a report on Tuesday, September 22nd. Six analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $26.00.
Shares of Relx stock opened at $22.04 on Friday. The stock has a market cap of $42.57 billion, a P/E ratio of 18.52, a P/E/G ratio of 3.34 and a beta of 0.53. The stock’s 50 day simple moving average is $22.56 and its 200-day simple moving average is $22.66. Relx PLC has a 1-year low of $16.81 and a 1-year high of $27.25. The company has a debt-to-equity ratio of 3.15, a current ratio of 0.47 and a quick ratio of 0.42.
Relx Company Profile
RELX PLC provides information based-analytics and decision tools for professional and business customers in the United States and internationally. It operates through four segments: Scientific, Technical & Medical; Risk & Business Analytics; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics to institutions and professionals that enables progress in science, advance healthcare, and performance improvement.
Featured Story: What is the Fibonacci sequence?
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx PLC (NYSE:RELX).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.